NCT03331458 Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study Status COMPLETED Phase NA
NCT03331367 Investigating and Characterizing the Immune Response to Prostate Cancer Status COMPLETED Phase NA
NCT03331068 French Validation of the Memorial Anxiety Scale for Patients With Prostate Cancer. Status COMPLETED Phase N/A
NCT03328091 Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen) Status COMPLETED Phase NA
NCT03327675 High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer Status RECRUITING Phase NA
NCT03322891 Improving Health Literacy in African-American Prostate Cancer Patients Status RECRUITING Phase NA
NCT03321864 Capture of Prostatic Trans-rectal Ultrasound Scans for Research Status SUSPENDED Phase NA
NCT03321149 Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation Therapy Status COMPLETED Phase NA
NCT03317990 Evaluating the Effects of Frozen Section Technology on Oncological and Functional Outcomes at Radical Prostatectomy. Status ACTIVE_NOT_RECRUITING Phase NA
NCT03315871 Combination Immunotherapy in Biochemically Recurrent Prostate Cancer Status COMPLETED Phase PHASE2
NCT03315585 The Efficacy and Safety of Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Focal Therapy Status COMPLETED Phase NA
NCT03311555 A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR) Status COMPLETED Phase PHASE2
NCT03310541 AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations Status COMPLETED Phase PHASE1
NCT03308734 Effects of 6 Week Reduced Exertion High Intensity Interval Training Protocol in Patients With Prostate Cancer Status WITHDRAWN Phase NA
NCT03307460 uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness Status UNKNOWN Phase PHASE2
NCT03300505 ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer Status TERMINATED Phase PHASE1
NCT03297385 Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation Status COMPLETED Phase PHASE2
NCT03296124 Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32) Status WITHDRAWN Phase N/A
NCT03294889 ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer Status RECRUITING Phase PHASE1/PHASE2